← Rentoceratib

What podcasts say about Rentoceratib

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Rentoceratib

2 statements · 2 positive

  1. Insilico’s rentoceratib advanced to Phase 3 trials for idiopathic pulmonary fibrosis.

    “rentoceratib has advanced to phase 3 trials in idiopathic pulmonary fibrosis”

    Listen at 2:10:59

    Open the episode · Should we slow down AI progress? | MOONSHOTS #288
  2. Insilico’s Phase 2a study showed three to four years of biological age reversal after four weeks.

    “at week 4, they saw, according to these proteomic aging clocks, 3 to 4 years of biological age reversal.”

    Listen at 2:13:19

    Open the episode · Should we slow down AI progress? | MOONSHOTS #288

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.